UNSPSC 51141577: Ropizine

This classification denotes an anticonvulsant agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Q5128GW9D4. European Medicines Agency schedules Ropizine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10383MIG. Ropizine generally arises in the molecular formula C24H26N4.

UNSPSC 51141577 Ropizine is a Commodity code that covers pharmaceutical products and medical countermeasures procured by state and local health agencies, though the recent solicitation record shows the code is being applied to naloxone and drug deactivation system procurement. State and local government buyers under this code include county health departments and public health authorities managing emergency response and community health initiatives. The work solicited involves purchasing finished pharmaceutical products and related medical systems for distribution through public health channels, with vendors required to meet federal compliance standards including E-Verify, drug-free workplace certification, and federal environmental regulations when funding involves FEMA or other federal sources.

Seminole County, Florida represents the primary recent activity on record. The county issued IFB 60459723LAS in June 2026 to procure 1,900 units of naloxone and 800 safe drug deactivation systems annually through July 26, 2023, with quarterly deliveries to the Seminole County Community Health Building in Sanford. The solicitation required electronic bid submission through the county's e-Procurement Portal, inclusion of all shipping and delivery costs, unit pricing for each line item, and compliance with insurance, workers' compensation, and professional liability requirements. The initial contract term was two years with a one-year renewal option, and bidders faced a three-month probationary period with termination at will.